Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma

Annals of Nuclear Medicine

Volumn 24, Issue 6, 2010, Pages 441-446

  Middendorp, Marcus ^a   Maute, Luise ^a   Sauter, Bruno ^a   Vogl, Thomas J ^a   Grünwald, Frank ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Fluoroethylcholine; PET CT; Renal cell carcinoma

Indexed keywords

FLUOROETHYLCHOLINE F 18; RADIOPHARMACEUTICAL AGENT; SUNITINIB; UNCLASSIFIED DRUG; CHOLINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUOROETHYLCHOLINE;

ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CASE REPORT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METABOLISM; NEPHRECTOMY; PANCREAS RESECTION; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPLENECTOMY; KIDNEY TUMOR; PATHOLOGY; TREATMENT OUTCOME;

AGED; CARCINOMA, RENAL CELL; CHOLINE; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77955466323     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-010-0375-9     Document Type: Article

References (17)

1. JW Park MK Jo HM Lee 2009 Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma BJU Int 103 615 619 10.1111/j.1464-410X.2008.08150.x 19007371
2. D Lyrdal M Boijsen M Suurküla S Lundstam U Stierner 2009 Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-fluoro-2-deoxyglucose positron emission tomography and computed tomography Nucl Med Commun 30 519 524 10.1097/MNM.0b013e32832cc220 1:CAS:528: DC%2BD1MXosFCru7w%3D 19522059
3. T Powles I Murray C Brock T Oliver N Avril 2007 Molecular positron emission tomography and PET/CT imaging in urological malignancies Eur Urol 51 1511 1520 10.1016/j.eururo.2007.01.061 17275167 (Pubitemid 46634756)
4. SR Martínez de Llano RC Delgado-Bolton A Jiménez-Vicioso MJ Pérez-Castejón JL Carreras Delgado E Ramos, et al. 2007 Meta-analysis of the diagnostic performance of 18F-FDG PET in renal cell carcinoma Rev Esp Med Nucl 26 19 29 10.1157/13097378 17286945 (Pubitemid 46375281)
5. M Ide Y Suzuki G Kameyama W Takahashi S Koide S Hinohara, et al. 2005 The detection of renal cell carcinoma with adrenal and para-aortic lymph node metastases by FDG-PET Eur J Nucl Med Mol Imaging 32 1246 10.1007/s00259-005- 1870-4 16133385 (Pubitemid 41355957)
6. D Snow D Cohen WC Chapman RL Grubb 3rd 2009 Positron emission tomography enhancing tumor thrombus in patient with renal cell carcinoma Urology 73 270 271 10.1016/j.urology.2008.08.463 18950838
7. GM Thambugala A Mohamed GF O'Neill MJ Fulham 2006 Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT Australas Radiol 50 604 606 10.1111/j.1440-1673.2006.01664.x 1:STN:280:DC%2BD28nntVeltA%3D%3D 17107535 (Pubitemid 44748088)
8. J Kotzerke C Linné M Meinhardt J Steinbach M Wirth G Baretton, et al. 2007 [1-(11)C]acetate uptake is not increased in renal cell carcinoma Eur J Nucl Med Mol Imaging 34 884 888 10.1007/s00259-006-0362-5 1:CAS:528: DC%2BD2sXltl2htLs%3D 17262213 (Pubitemid 46798961)
9. N Oyama H Okazawa N Kusukawa T Kaneda Y Miwa H Akino, et al. 2009 11C-Acetate PET imaging for renal cell carcinoma Eur J Nucl Med Mol Imaging 36 422 427 10.1007/s00259-008-0981-0 19018529
10. N Lawrentschuk AM Poon AM Scott 2006 Fluorine-18 fluorothymidine: a new positron emission radioisotope for renal tumors Clin Nucl Med 31 788 789 10.1097/01.rlu.0000247310.05362.83 17117073 (Pubitemid 44789558)
11. DM Schuster JA Nye PT Nieh JR Votaw RK Halkar MM Issa, et al. 2009 Initial experience with the radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane- 1-carboxylic acid (anti-[(18)F]FACBC) with PET in renal carcinoma Mol Imaging Biol 11 434 438 10.1007/s11307-009-0220-5 19449079
12. CR Divgi N Pandit-Taskar AA Jungbluth VE Reuter M Gönen S Ruan, et al. 2007 Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial Lancet Oncol 8 304 310 10.1016/S1470-2045(07) 70044-X 1:CAS:528:DC%2BD2sXjslGrtLY%3D 17395103 (Pubitemid 46464522)
13. N Lawrentschuk AM Poon SS Foo LG Putra C Murone ID Davis, et al. 2005 Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography BJU Int 96 540 546 10.1111/j.1464-410X.2005.05681.x 16104907 (Pubitemid 41224324)
14. P Bhargava M Hanif C Nash 2008 Whole-body F-18 sodium fluoride PET-CT in a patient with renal cell carcinoma Clin Nucl Med 33 894 895 10.1097/RLU.0b013e31818ca43c 19033802
15. CH Chang YC Shiau YY Shen A Kao CC Lin CC Lee 2003 Differentiating solitary pulmonary metastases in patients with renal cell carcinomas by 18F-fluoro-2-deoxyglucose positron emission tomography-a preliminary report Urol Int 71 306 309 10.1159/000072683 1:CAS:528:DC%2BD3sXnsF2nu7o%3D 14512653 (Pubitemid 37186748)
16. L Vercellino G Bousquet G Baillet E Barré O Mathieu PA Just, et al. 2009 18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: preliminary study Cancer Biother Radiopharm 24 137 144 10.1089/cbr.2008.0527 1:CAS:528:DC%2BD1MXisVSrt7Y%3D 19243256
17. A Maleddu MA Pantaleo P Castellucci M Astorino C Nanni M Nannini, et al. 2009 11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma Tumori 95 382 384 1:CAS:528:DC%2BD1MXps1Wgu78%3D 19688982